IHF (IHF) ETF Analysis
The IHF ETF provides focused exposure to the US Healthcare Providers sector, holding just 10 companies. With top allocations to UnitedHealth Group Inc (20.86%) and CVS Health Corp (13.24%), IHF offers a concentrated bet on the industry's leaders. Its 3-year beta of 0.69 suggests lower volatility compared to the broader market. IHF distinguishes itself through its narrow focus and concentrated portfolio within the healthcare sector.
IHF (IHF) ETF — Price, Holdings & Analysis
ETF Overview
Risk Metrics
Top Holdings
- UnitedHealth Group Inc (UNH): 20.86%
- CVS Health Corp (CVS): 13.24%
- Elevance Health Inc (ELV): 9.29%
- HCA Healthcare Inc (HCA): 5.28%
- The Cigna Group (CI): 5.15%
- Labcorp Holdings Inc (LH): 4.05%
- Quest Diagnostics Inc (DGX): 3.98%
- Veeva Systems Inc Class A (VEEV): 3.71%
- Tenet Healthcare Corp (THC): 3.55%
- Centene Corp (CNC): 3.54%
Dividend Yield
Risk Metrics
- Beta: 0.69
Questions & Answers
What is IHF and what does it track?
IHF is an ETF that focuses specifically on companies within the Healthcare Providers industry in the United States. It aims to track the performance of an index composed of these companies, offering investors a targeted way to gain exposure to this specific segment of the healthcare sector. With only 10 holdings, IHF provides a concentrated bet on the industry's leaders, such as UnitedHealth Group Inc and CVS Health Corp. This makes it distinct from broader healthcare ETFs that include a wider range of healthcare-related companies.
What is the expense ratio for IHF?
While the expense ratio for IHF is not explicitly provided, it's important to consider expense ratios when evaluating any ETF. Expense ratios represent the annual cost of owning the ETF, expressed as a percentage of the fund's assets. A lower expense ratio means that more of the fund's returns are passed on to investors. Investors should compare IHF's expense ratio to similar healthcare ETFs to determine its cost-effectiveness.
What are the top holdings in IHF?
IHF's top holdings are concentrated in a few key players within the Healthcare Providers industry. As of 2026-03-15, the top three holdings are UnitedHealth Group Inc (UNH) at 20.86%, CVS Health Corp (CVS) at 13.24%, and Elevance Health Inc (ELV) at 9.29%. These companies represent a significant portion of the fund's assets, reflecting its focused investment strategy. The performance of these top holdings will have a substantial impact on the overall performance of IHF.
Is IHF a good long-term investment?
Whether IHF is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and outlook on the Healthcare Providers industry. IHF offers targeted exposure to this specific sector, which can be beneficial if the sector performs well. However, its concentrated portfolio and sector focus also introduce risks. the may be worth researching fund's historical performance, expense ratio, and the potential for regulatory changes or technological disruptions to impact the healthcare industry. Past performance does not guarantee future results.
How does IHF compare to similar ETFs?
IHF distinguishes itself from similar ETFs through its narrow focus on Healthcare Providers and its highly concentrated portfolio. Many healthcare ETFs offer broader exposure to the healthcare industry, including pharmaceutical companies, medical device manufacturers, and biotechnology firms. IHF's concentrated approach means that its performance is more closely tied to the performance of a few key companies. Investors should compare IHF's expense ratio, AUM, and historical performance to those of other healthcare ETFs to determine which fund best aligns with their investment objectives.
Does IHF pay dividends?
According to the provided data, IHF has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders. Investors seeking income from their investments may want to consider other ETFs with a higher dividend yield. However, IHF's focus is primarily on capital appreciation through the growth of its underlying holdings.